50 A systematic review and meta‐analysis involving 11 studies and 582 patients found a marginally significant benefit of IVIg in women with RPL. 51 Further subgroup analysis found differing outcomes depending on the timing of IVIg treatment, with administration prior to conception associated with an increased LBR.
← all excerpts
Australasian recurrent pregnancy loss clinical management guideline 2024, part II.
1
—
—